SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Applied Genetic Technologies Corp – ‘8-A12B’ on 3/24/14

On:  Monday, 3/24/14, at 12:20pm ET   ·   Accession #:  1193125-14-111803   ·   File #:  1-36370

7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/24/14  Applied Genetic Technologies Corp 8-A12B                 1:14K                                    Donnelley … Solutions/FA

Registration of a Class of Securities   —   Form 8-A
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-A12B      Registration of a Class of Securities               HTML     13K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  8-A12B  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

Applied Genetic Technologies Corporation

(Exact name of registrant as specified in its charter)

 

 

Delaware    59-3553710
(State of incorporation or organization)    (I.R.S. Employer Identification No.)
11801 Research Drive, Suite D, Alachua, Florida    32615
(Address of principal executive offices)    (Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

Common Stock, $0.001 par value per share

  The NASDAQ Stock Market LLC

 

 

 

 

 

 

 

 

 

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. ¨

Securities Act registration statement file number to which this form relates:                 333-193309                 (if applicable).

Securities to be registered pursuant to Section 12(g) of the Act:

None

 

(Title of class)

 

 

 

(Title of class)


INFORMATION REQUIRED IN REGISTRATION STATEMENT

 

Item 1. Description of Registrant’s Securities to be Registered.

A description of the common stock, $0.001 par value per share (the “Common Stock”), of Applied Genetic Technologies Corporation, a Delaware corporation (the “Registrant”), to be registered hereunder is set forth under the heading “Description of Capital Stock” in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-193309), initially filed with the Securities and Exchange Commission (the “Commission”) on January 10, 2014, as subsequently amended (the “Registration Statement”), and is incorporated herein by reference. In addition, a description of the Common Stock will be included in a prospectus to be subsequently filed by the Registrant with the Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, relating to the Registration Statement, and such prospectus is incorporated herein by reference.

 

Item 2. Exhibits.

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereunder are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

 

2


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

    APPLIED GENETIC TECHNOLOGIES CORPORATION
Date: March 24, 2014     By:   /s/ Susan B. Washer
     

Susan B. Washer

Chief Executive Officer and President

 

3


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-A12B’ Filing    Date    Other Filings
Filed on:3/24/14CORRESP
1/10/14DRS,  DRS/A,  S-1
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/14/22  Applied Genetic Techs Corp.       424B5                  1:517K                                   Donnelley … Solutions/FA
 7/12/22  Applied Genetic Techs Corp.       424B5                  1:541K                                   Donnelley … Solutions/FA
 3/23/22  Applied Genetic Techs Corp.       424B5                  1:460K                                   Donnelley … Solutions/FA
 3/21/22  Applied Genetic Techs Corp.       424B5                  1:463K                                   Donnelley … Solutions/FA
 4/02/21  Applied Genetic Techs Corp.       S-3                    5:1M                                     Donnelley … Solutions/FA
 1/29/21  Applied Genetic Techs Corp.       424B5                  1:538K                                   Donnelley … Solutions/FA
 1/27/21  Applied Genetic Techs Corp.       424B5                  1:564K                                   Donnelley … Solutions/FA
Top
Filing Submission 0001193125-14-111803   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 2, 10:14:15.1am ET